Market Overview

Research and Markets: Global Psoriasis Epidemiology and Patient Flow Analysis - 2012

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/6bc89f/global_psoriasis) has announced the addition of the "Global Psoriasis Epidemiology and Patient Flow Analysis - 2012" report to their offering.

Fore Pharma announced the results of its Psoriasis patient population study in a new report Global Psoriasis Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Psoriasis epidemiology, Psoriasis diagnosed patients, and Psoriasis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Psoriasis derived from epidemiological analysis, percentage of patients diagnosed with Psoriasis, and percentage of patients treated with Psoriasis therapy.

The study helps executives estimate Psoriasis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Psoriasis prevalence, Psoriasis diagnosis rate, and Psoriasis treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:

- Psoriasis: Disease Definition

- Psoriasis Patient Flow

- Psoriasis Prevalence

- Psoriasis Diagnosed Patients

- Psoriasis Treated Patients

For more information visit http://www.researchandmarkets.com/research/6bc89f/global_psoriasis

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

 

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional